0 Commentaires
0 Parts
194 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Generic Drug Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook" According to the latest report published by Data Bridge Market Research, the Generic Drug Market Data Bridge Market Research analyses that the generic drug market, which is USD 622.02 million in 2022, is expected to reach USD 1,323.68 million by 2030, at a CAGR of 9.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market...0 Commentaires 0 Parts 152 Vue 0 Aperçu
-
Generic Oncology Drug Market – Cost Reduction and Global Cancer AccessMarket Overview The generic oncology drug market is critical to global cancer care as generic versions of chemotherapy, hormonal therapy, and targeted treatments dramatically reduce costs while expanding access to life-saving medicines in low and middle-income countries. With cancer incidence rising globally and many patented drugs priced beyond patient means, generics enable treatment...0 Commentaires 0 Parts 90 Vue 0 Aperçu
-
Generic Oncology Drug Market – Cost-Effective Cancer Treatment Expanding Global AccessMarket Overview The generic oncology drug market is growing steadily as patent expirations on established cancer therapies open the door to more affordable treatment alternatives across chemotherapy and targeted therapy categories. Generic oncology drugs provide the same active therapeutic ingredients as branded counterparts at significantly reduced costs, improving access for patients and...0 Commentaires 0 Parts 71 Vue 0 Aperçu
-
Pharmerging Market - Generic Drug Production and Cost-Effective TreatmentMarket Overview The pharmerging market is experiencing generic medicine emphasis where generic drug manufacturing, affordability focus, and cost-effective treatments meet healthcare access needs in emerging economies. The pharmerging market is projected to exceed USD 684.2 billion through 2030, with generic emphasis driven by affordability necessity, disease burden, and cost constraints....0 Commentaires 0 Parts 212 Vue 0 Aperçu
-
This article explores the growth of the Glycopyrronium Bromide API Market, driven by the rising prevalence of respiratory diseases like COPD, advancements in drug formulation, and the expanding generic API sector.Chronic respiratory diseases, including Chronic Obstructive Pulmonary Disease (COPD) and asthma, represent a significant and growing global health burden. At the heart of effective treatments for these conditions are active pharmaceutical ingredients (APIs) like Glycopyrronium Bromide, a potent anticholinergic bronchodilator. The Glycopyrronium Bromide API Market, valued at USD 300 Million in...0 Commentaires 0 Parts 119 Vue 0 Aperçu
-
Global Cefalexin API Market to Reach USD 871 Million by 2034According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Lithium Salts Market Development Trends and Industry OverviewThe global Lithium Salts Market is witnessing substantial growth driven by rising demand from the pharmaceutical sector, increasing adoption of lithium-based compounds in healthcare treatments, and expanding research activities focused on mental health disorders. Lithium salts play a critical role in the treatment of bipolar disorder, depression, and various neurological conditions, making them...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek